Exodus Point Capital Management, LP Tyme Technologies, Inc. Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$0.6 - $1.04 $16,032 - $27,789
-26,721 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$0.99 - $1.38 $28,925 - $40,320
-29,218 Reduced 52.23%
26,721 $28,000
Q2 2021

Aug 16, 2021
BUY
$1.14 - $1.87 $36,272 - $59,499
31,818 Added 131.91%
55,939 $70,000
Q1 2021

May 17, 2021
BUY
$1.34 - $3.53 $32,322 - $85,147
24,121 New
24,121 $43,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email